How to read the normal cervical cancer screening report sheet

The normal cervical cancer screening report sheet mainly focuses on two core indicators: HPV test results and TCT test results. If the HPV test is negative and TCT shows no intraepithelial lesions or malignant cells, it is a normal result. If abnormalities are found, further examination is required based on the doctor's recommendations.

HPV test results are divided into negative and positive. A negative result means that no high-risk human papillomavirus infection has been found. A positive result requires clear identification of the specific type. A high-risk test positive for type 16/18 requires immediate referral for colposcopy. A positive test for other high-risk types needs to be judged based on TCT results. The TCT report mainly observes the description of squamous epithelial cells. Normal results are expressed as no intraepithelial lesions or malignant cells. Abnormalities include atypical squamous cells, low-grade squamous intraepithelial lesions, high-grade squamous intraepithelial lesions and other grades. The report form will also indicate the sample quality assessment. Satisfactory samples must contain a sufficient number of cervical glandular cells and squamous epithelial cells. Unsatisfactory samples may affect the accuracy of the results and require resampling.

The cervical cancer screening report sheet may contain Bethesda system terminology. Please pay attention to special expressions such as atypical squamous cells - unclear meaning, atypical glandular cells, etc. Some reports will add hints of microbial infections, such as Candida and Trichomonas, which are not directly related to cervical cancer but require symptomatic treatment. The laboratory may give treatment suggestions for abnormal results, such as reexamination in 6-12 months or colposcopy, but the final decision must be based on the comprehensive evaluation of the clinician.

Regular cervical cancer screening is the key to prevention. It is recommended that women aged 21-29 years old undergo TCT examination every 3 years, and women aged 30-65 years old can choose to undergo combined HPV and TCT testing every 5 years. Healthy lifestyles such as maintaining a single sexual partner, getting the HPV vaccine, and avoiding smoking can reduce the risk of the disease. If abnormalities are found during screening, there is no need to be overly anxious. Most cervical lesions develop slowly and are reversible. Timely intervention can effectively block the cancer process.